136 related articles for article (PubMed ID: 35418342)
1. Evaluating Regional Nodal Irradiation Allocation and Association with Oncologic Outcomes in NSABP B-18, B-27, B-40, and B-41.
Mailhot Vega RB; Wang S; Brooks ED; Oladeru OT; Lockney NA; Spiguel LE; MacDonald SM; Mamounas EP; Mendenhall NP; Okunieff PG; Lee JH; Bradley JA
Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):542-551. PubMed ID: 35418342
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.
Stecklein SR; Park M; Liu DD; Valle Goffin JJ; Caudle AS; Mittendorf EA; Barcenas CH; Mougalian S; Woodward WA; Valero V; Sahin AA; Yang WT; Shaitelman SF
Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):568-577. PubMed ID: 29928946
[TBL] [Abstract][Full Text] [Related]
3. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
4. Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast cancer.
Kim N; Kim JY; Park W; Cho WK; Kim TG; Im YH; Ahn JS; Lee JE; Nam SJ; Kim SW; Yu J; Chae BJ; Lee SK; Ryu JM; Park YH; Kim H
Breast; 2023 Dec; 72():103594. PubMed ID: 37924622
[TBL] [Abstract][Full Text] [Related]
5. Regional Nodal Irradiation for Clinically Node-Positive Breast Cancer Patients With Pathologic Negative Nodes After Neoadjuvant Chemotherapy.
Schlafstein A; Liu Y; Goyal S; Kahn S; Godette K; Lin J; Torres MA; Royce TJ; Patel SA
Clin Breast Cancer; 2022 Feb; 22(2):127-135. PubMed ID: 34229943
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Neo-Bioscore Staging System in Guiding the Optimal Strategies for Regional Nodal Irradiation Following Neoadjuvant Treatment in Breast Cancer Patients with cN1 and ypN0-1.
Cao L; Xu C; Kirova YM; Cai G; Cai R; Wang SB; Shen KW; Ou D; Chen JY
Ann Surg Oncol; 2019 Feb; 26(2):343-355. PubMed ID: 30519764
[TBL] [Abstract][Full Text] [Related]
7. Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Gingras I; Holmes E; De Azambuja E; Nguyen DH; Izquierdo M; Anne Zujewski J; Inbar M; Naume B; Tomasello G; Gralow JR; Wolff AC; Harris L; Gnant M; Moreno-Aspitia A; Piccart MJ; Azim HA
J Natl Cancer Inst; 2017 Aug; 109(8):. PubMed ID: 28376188
[TBL] [Abstract][Full Text] [Related]
8. Does Failure to Achieve Pathologic Complete Response with Neoadjuvant Chemotherapy Identify Node-Negative Patients Who Would Benefit from Postmastectomy Radiation or Regional Nodal Irradiation?
Crown A; Gonen M; Le T; Morrow M
Ann Surg Oncol; 2021 Mar; 28(3):1328-1335. PubMed ID: 32959140
[TBL] [Abstract][Full Text] [Related]
9. Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.
Mamounas EP; Anderson SJ; Dignam JJ; Bear HD; Julian TB; Geyer CE; Taghian A; Wickerham DL; Wolmark N
J Clin Oncol; 2012 Nov; 30(32):3960-6. PubMed ID: 23032615
[TBL] [Abstract][Full Text] [Related]
10. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.
Caudle AS; Yu TK; Tucker SL; Bedrosian I; Litton JK; Gonzalez-Angulo AM; Hoffman K; Meric-Bernstam F; Hunt KK; Buchholz TA; Mittendorf EA
Breast Cancer Res; 2012 May; 14(3):R83. PubMed ID: 22621334
[TBL] [Abstract][Full Text] [Related]
11. Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions.
Sun GY; Wen G; Zhang YJ; Tang Y; Jing H; Fang H; Wang JY; Zhang JH; Zhao XR; Chen SY; Song YW; Jin J; Liu YP; Tang Y; Qi SN; Li N; Chen B; Lu NN; Li YX; Wang SL
Front Oncol; 2022; 12():955381. PubMed ID: 36605447
[TBL] [Abstract][Full Text] [Related]
12. Role of Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer Patients: A Study from the Japanese Breast Cancer Registry.
Miyashita M; Niikura N; Kumamaru H; Miyata H; Iwamoto T; Kawai M; Anan K; Hayashi N; Aogi K; Ishida T; Masuoka H; Iijima K; Masuda S; Tsugawa K; Kinoshita T; Tsuda H; Nakamura S; Tokuda Y
Ann Surg Oncol; 2019 Aug; 26(8):2475-2485. PubMed ID: 31102090
[TBL] [Abstract][Full Text] [Related]
13. Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy.
Swisher SK; Vila J; Tucker SL; Bedrosian I; Shaitelman SF; Litton JK; Smith BD; Caudle AS; Kuerer HM; Mittendorf EA
Ann Surg Oncol; 2016 Mar; 23(3):749-56. PubMed ID: 26511263
[TBL] [Abstract][Full Text] [Related]
14. Regional nodal irradiation (RNI) in breast cancer patients with residual isolated tumor cells or micrometastatic nodal disease after neoadjuvant chemotherapy.
Kim JK; Karp JM; Gerber NK
Clin Transl Radiat Oncol; 2023 Jan; 38():195-201. PubMed ID: 36479237
[TBL] [Abstract][Full Text] [Related]
15. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
16. Association Between Regional Nodal Irradiation and Breast Cancer Recurrence-Free Interval for Patients With Low-Risk, Node-Positive Breast Cancer.
Sit D; Lalani N; Chan E; Tran E; Speers C; Gondara L; Chia S; Gelmon K; Lohrisch C; Nichol A
Int J Radiat Oncol Biol Phys; 2022 Mar; 112(4):861-869. PubMed ID: 34762971
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation.
Keilty D; Nezafat Namini S; Swain M; Maganti M; Cil TD; McCready DR; Cescon DW; Amir E; Fleming R; Mulligan AM; Fyles A; Croke JM; Liu FF; Levin W; Koch CA; Han K
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):676-685. PubMed ID: 32407932
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for regional nodal failure after breast-conserving therapy: regional nodal irradiation reduces rate of axillary failure in patients with four or more positive lymph nodes.
Grills IS; Kestin LL; Goldstein N; Mitchell C; Martinez A; Ingold J; Vicini FA
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):658-70. PubMed ID: 12788171
[TBL] [Abstract][Full Text] [Related]
19. Patterns of practice of regional nodal irradiation in breast cancer: results of the European Organization for Research and Treatment of Cancer (EORTC) NOdal Radiotherapy (NORA) survey.
Belkacemi Y; Kaidar-Person O; Poortmans P; Ozsahin M; Valli MC; Russell N; Kunkler I; Hermans J; Kuten A; van Tienhoven G; Westenberg H;
Ann Oncol; 2015 Mar; 26(3):529-35. PubMed ID: 25480875
[TBL] [Abstract][Full Text] [Related]
20. Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis.
Moreno AC; Lin YH; Bedrosian I; Shen Y; Stauder MC; Smith BD; Buchholz TA; Babiera GV; Woodward WA; Shaitelman SF
Adv Radiat Oncol; 2017; 2(3):291-300. PubMed ID: 29114595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
